share_log

Roth MKM Reiterates Buy on Globus Medical, Maintains $100 Price Target

Benzinga ·  01:38  · Ratings

Roth MKM analyst Jason Wittes reiterates Globus Medical (NYSE:GMED) with a Buy and maintains $100 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment